182
Participants
Start Date
May 31, 2009
Primary Completion Date
June 30, 2011
Study Completion Date
September 30, 2011
CM-AT
Single unit dose powder of active substance (CM-AT) administered 3 times per day for 90 days
Placebo
Single unit dose powder of non-active substance administered 3 times per day for 90 days
Mount Sinai School of Medicine, New York
University of Pittsburgh, Pittsburgh
Hershey Medical Center, Hershey
Drexel University, Philadelphia
University of North Carolina, Chapel Hill
Institute for Behavioral Medicine, Smyrna
Lake Mary Pediatrics, Orange City
Ohio State University, Columbus
Alexian Brothers Center for Psychiatric Research, Hoffman Estates
Louisiana State University Health Science Center, Shreveport
Oklahoma University Child Study Center, Oklahoma City
University of Texas, Houston, Houston
Westside Medical, Clinton
Southwest Autism Research and Resource Center, Phoenix
Neuropsychiatric Research Center of Orange County, Santa Ana
University of California, San Francisco, San Francisco
University of California, Davis, M.I.N.D. Institute, Sacramento
Cyn3rgy Research, Gresham
Saint Peters University Hospital, New Brunswick
Lead Sponsor
Curemark
INDUSTRY